Cell Biosciences Inc. agreed to pay $12 million for Toronto-based Convergent Bioscience Ltd. in a deal expected to close by the end of the month.
Convergent Bioscience, which employs 45 people, makes imaging capillary electrophoresis equipment for protein charge heterogeneity characterization, a quality control measurement used during protein biologics production. The company is expected to pull in nearly $8 million in sales this year, according to a press release.